InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,299.12
(
0.59%
)
US TECH 100
18,310.40
(
0.90%
)
Dow Jones
39,054.12
(
-0.03%
)
Brent Oil
81.90
(
0.73%
)
Bitcoin
68,968.47
(
1.54%
)
Post# of 459809
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 482
Posts 60573
Boards Moderated 18
Alias Born 09/20/2001

XenaLives

Member Level

Re: Investor2014 post# 288995

Sunday, 12/20/2020 10:55:02 AM

Sunday, December 20, 2020 10:55:02 AM

Post# of 459809
You have confirmed my statement..

Patient and/or Dr. would have confirmed availability for a SAS application before submitting it to the TGA.

So now that the TGA has put it on their list of approvable special access drugs if Anavex Doctor and Patient concur it is up to the Doctor to make a SAS request.

No additional requirements per disease or trial are required, just a statement from the doctor that it is a patient's only hope.


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!